Billiontoone, Inc.

9 patents currently held · Updated Nov 14, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Aug 2038

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Oct 2, 2027
The maintenance fee for Non-invasive prenatal testing at early stage of pregnancy (US 11,946,104) comes due Oct 2, 2027. Unpaid by Apr 3, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 9 of 9

Patent	Title	Status	Expires	Confidence
US 12,176,066	Target-Associated Molecules for Characterization Associated with Biological Targets In force Ends no later than Aug 6, 2038 · Medium confidence	In force	Ends no later than Aug 6, 2038	Medium confidence
US 12,183,437	Sequencing output determination and analysis with target-associated molecules in quantification associated with biological targets In force Term ends Dec 20, 2038 · From the USPTO record	In force	Term ends Dec 20, 2038	From the USPTO record
US 11,519,024	Homologous genomic regions for characterization associated with biological targets In force Term ends Mar 25, 2040 · From the USPTO record	In force	Term ends Mar 25, 2040	From the USPTO record
US 11,946,104	Non-invasive prenatal testing at early stage of pregnancy In force Term ends Jul 7, 2040 · From the USPTO record	In force	Term ends Jul 7, 2040	From the USPTO record
US 12,071,651	Dilution tagging for quantification of biological targets In force Term ends Mar 19, 2041 · From the USPTO record	In force	Term ends Mar 19, 2041	From the USPTO record
US 11,430,543	Sequencing output determination and analysis with target-associated molecules in quantification associated with biological targets In force Term ends Jun 24, 2041 · From the USPTO record	In force	Term ends Jun 24, 2041	From the USPTO record
US 11,629,381	Quality Control Templates Ensuring Validity of Sequencing-Based Assays In force Term ends Feb 17, 2042 · High confidence	In force	Term ends Feb 17, 2042	High confidence
US 11,646,100	Target-Associated Molecules for Characterization Associated with Biological Targets In force Term ends Mar 5, 2042 · High confidence	In force	Term ends Mar 5, 2042	High confidence
US 12,043,873	Molecule Counting of Methylated Cell-Free DNA for Treatment Monitoring In force Term ends Mar 21, 2043 · High confidence	In force	Term ends Mar 21, 2043	High confidence

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 pending · 4 no status recorded

List them